3H-cholesterol bound to albumin ( DrugBank: Cholesterol )

---

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
259	レシチンコレステロールアシルトランスフェラーゼ欠損症	1
261	タンジール病	1

259. レシチンコレステロールアシルトランスフェラーゼ欠損症

---

臨床試験数 : 1 /  薬物数 : 2 - (DrugBank : 1) / 標的遺伝子数 : 0 - 標的パスウェイ数 : 0

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01782027 (ClinicalTrials.gov)	October 2012	30/1/2013	Mendelian Reverse Cholesterol Transport Study	A Validation Study Evaluating the Use of 3H-Cholesterol Bound to Albumin as a Method to Assess Reverse Cholesterol Transport in Subjects With Monogenic Diseases Affecting HDL Metabolism	Cholesterol, HDL;Lipid Metabolism, Inborn Errors;Tangier Disease;LCAT Deficiency;Cholesteryl Ester Transfer Protein (CETP) Deficiency	Drug: 3H-cholesterol bound to albumin	University of Pennsylvania	NULL	Suspended	18 Years	75 Years	All	30	N/A	United States

261. タンジール病

---

臨床試験数 : 1 /  薬物数 : 2 - (DrugBank : 1) / 標的遺伝子数 : 0 - 標的パスウェイ数 : 0

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01782027 (ClinicalTrials.gov)	October 2012	30/1/2013	Mendelian Reverse Cholesterol Transport Study	A Validation Study Evaluating the Use of 3H-Cholesterol Bound to Albumin as a Method to Assess Reverse Cholesterol Transport in Subjects With Monogenic Diseases Affecting HDL Metabolism	Cholesterol, HDL;Lipid Metabolism, Inborn Errors;Tangier Disease;LCAT Deficiency;Cholesteryl Ester Transfer Protein (CETP) Deficiency	Drug: 3H-cholesterol bound to albumin	University of Pennsylvania	NULL	Suspended	18 Years	75 Years	All	30	N/A	United States